The valvular heart disease – ppt
The valvular heart disease – ppt Valvular heart disease (VHD) encompasses a range of conditions where one or more of the heart’s valves become damaged or dysfunctional, disrupting normal blood flow through the heart. The human heart contains four main valves: the mitral, tricuspid, aortic, and pulmonary valves. These valves ensure unidirectional blood flow, opening to allow blood to pass and closing to prevent backflow. When these valves are compromised, it can lead to significant cardiovascular problems, including heart failure, arrhythmias, and even sudden cardiac death.
VHD can be broadly classified into two categories: stenosis and regurgitation (or insufficiency). Stenosis refers to the narrowing of a valve, which impedes blood flow. Regurgitation involves the incomplete closure of a valve, resulting in backward flow of blood. Both conditions can be congenital or acquired. Congenital defects may involve malformed valves present from birth, such as bicuspid aortic valves. Acquired causes include rheumatic heart disease, infective endocarditis, degenerative calcification, and valve prolapse. The valvular heart disease – ppt
Rheumatic heart disease remains a leading cause of valvular pathology worldwide, especially in developing countries. It typically results from an abnormal immune response to Streptococcus pyogenes infection, leading to inflammation and scarring of the valves. Degenerative calcification, often affecting older adults, causes stiffening and narrowing of the valves, especially the aortic and mitral valves. Infective endocarditis involves bacterial infection that damages the valve tissue, creating vegetations that impair function.
Clinically, patients with VHD may present with symptoms such as exertional dyspnea, fatigue, palpitations, or chest pain. Severe cases can lead to signs of heart failure, including pulmonary edema or peripheral edema. The physical examination often reveals murmurs—audible turbulent blood flow sounds—characteristic of specific valve lesions. For example, a systolic murmur at the apex suggests mitral regurgitation, whereas a crescendo-decrescendo diastolic murmur at the second intercostal space indicates aortic stenosis. The valvular heart disease – ppt
Diagnosis relies heavily on echocardiography, which provides detailed visualization of valve morphology and function. Doppler echocardiography assesses the severity of stenosis or regurgitation by measuring blood flow velocities and pressure gradients. Additional investigations, such as chest X-rays, ECG, and cardiac MRI, aid in assessing chamber size, calcification, and the extent of cardiac remodeling. The valvular heart disease – ppt
Management of valvular heart disease depends on its severity and symptoms. Mild cases often require regular monitoring and medical management aimed at controlling symptoms and preventing complications. Medical treatments may include diuretics, vasodilators, or anticoagulants, especially in atrial fibrillation associated with mitral stenosis. For severe cases, surgical intervention is indicated. Valve repair is preferable when feasible, as it preserves native valve tissue, but valve replacement—either mechanical or bioprosthetic—is common when repair isn’t possible. The valvular heart disease – ppt
Advances in minimally invasive procedures, such as transcatheter valve replacement (TAVR), have transformed the treatment landscape, offering options for high-risk surgical patients. Long-term follow-up is essential, as prosthetic valves may require lifelong anticoagulation or periodic replacement.
Understanding valvular heart disease is critical, given its prevalence and impact on quality of life. Early detection and appropriate management can significantly improve patient outcomes and reduce the risk of severe complications. The valvular heart disease – ppt